CCM
NVO

Chiron Capital Management’s Novo Nordisk NVO Stock Holding History

Chiron Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$620K Buy
12,931
+1,589
+14% +$68.3K 0.56% 54
2026
Q1 		$417K Buy
+11,342
New +$537K 0.43% 61
2025
Q3 		$201K Buy
+3,628
New +$212K 0.17% 117

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Chiron Capital Management's NVO Position: Q2 2026 in Review

Chiron Capital Management increased its Novo Nordisk (NVO) stake by 14% in Q2 2026, buying an estimated $68.3K and bringing the position to 12,931 shares worth $620K. The position accounts for 0.56% of the portfolio, ranked #54.

Chiron Capital Management first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Chiron Capital Management held 12,931 shares of Novo Nordisk worth $620K as of Q2 2026.
  • Chiron Capital Management bought 1,589 Novo Nordisk shares in Q2 2026, an estimated $68.3K.
  • Novo Nordisk made up 0.56% of Chiron Capital Management's portfolio in Q2 2026, its #54 holding.
  • Chiron Capital Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.